Syncona Limited Change of Registered Office - Released in Error (7081K)
17 December 2018 - 11:38PM
UK Regulatory
TIDMSYNC
RNS Number : 7081K
Syncona Limited
17 December 2018
SYNCONA LIMITED
RELEASED IN ERROR
17 December 2018
The 'Change of Registered Office' announcement released on 17
December 2018 at 11.47am under RNS No 7019K was released in error
and should be disregarded.
[ENDS]
Enquiries
Syncona Ltd
Annabel Clay
Tel: +44 (0)20 3981 7928
Copies of this and other corporate information can be found on
the company website at: www.synconaltd.com
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on
founding, building and funding global leaders in life science. Our
vision is to deliver transformational treatments to patients in
truly innovative areas of healthcare while generating superior
returns for shareholders.
We seek to partner with the best, brightest and most ambitious
minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital,
and are established leaders in gene and cell therapy. We focus on
delivering dramatic efficacy for patients in areas of high unmet
need.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
CROFKODNBBDDBBD
(END) Dow Jones Newswires
December 17, 2018 07:38 ET (12:38 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2024 to May 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From May 2023 to May 2024